Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gynecological Cancer
Phenoxodiol may reverse gynecological cancer resistance to anticancer drugs
November 24th, 2005
Researchers from Yale University's School of Medicine have reported updated results from two clinical studies in women with late-stage ovarian cancer and early-stage cancer of the cervix and vagina that phenoxodiol (PXD) can be effective in reversing drug-resistance to anticancer drugs. The data were presented by Gil Mor, MD, PhD, associate professor of obstetrics, gynecology and reproductive sciences, Yale University School of Medicine, at the 11th World Congress on the Menopause, International Menopause Society in Buenos Aires, Argentina, and has been claimed as a breakthrough in management of these highly aggressive cancers. The ovarian cancer...
Source: Women's Health Weekly (2005-11-24)
|
